Hypertriglyceridemia
Clinical trials for Hypertriglyceridemia explained in plain language.
Never miss a new study
Get alerted when new Hypertriglyceridemia trials appear
Sign up with your email to follow new studies for Hypertriglyceridemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new siRNA injection keep high triglycerides in check for the long haul?
Disease control Not yet recruitingThis Phase 2 trial tests the long-term safety and effectiveness of HRS-7249, an investigational injection that targets a protein called APOC3 to lower triglycerides. The study includes people who previously took part in an earlier HRS-7249 trial, plus new participants aged 18 to …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Weekly shot aims to tame dangerous fat levels in the blood
Disease control Not yet recruitingThis Phase 3 trial tests an investigational biologic called DR10624, given as a weekly injection, in adults with severe hypertriglyceridemia (very high blood fats) who are already on standard lipid-lowering therapy. The study compares two doses of DR10624 against a placebo to see…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase 3 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could ozempic stop pancreatitis from coming back?
Prevention Not yet recruitingThis study tests whether semaglutide (Ozempic/Wegovy) can prevent repeat episodes of acute pancreatitis caused by very high triglycerides. About 396 adults who recently had such an attack will receive either semaglutide injections or a placebo for 18 months, alongside standard ca…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC